Bobby Gaspar

Insider Reports History

Location
London, United Kingdom
Signature
/s/ Frank Thomas, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Bobby Gaspar:

Company Role Class Num Shares Value Price $ Report Date Ownership
Orchard Therapeutics plc Chief Executive Officer, Director Ordinary Shares 0 $0.4591 24 Jan 2024 Direct
Orchard Therapeutics plc Chief Executive Officer, Director Stock Option (Right to Buy) 0 24 Jan 2024 Direct

Insider Reports Filed by Bobby Gaspar

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000095017024007058-gaspar-bobby-2024-01-24 Orchard Therapeutics plc 24 Jan 2024 13 $0 4 Chief Executive Officer, Director 24 Jan 2024, 17:18
/report/000120919123015879-gaspar-bobby-2023-03-01 Orchard Therapeutics plc 01 Mar 2023 2 $0 4 Chief Executive Officer, Director 03 Mar 2023, 17:00
/report/000120919122053004-gaspar-bobby-2022-10-04 Orchard Therapeutics plc 04 Oct 2022 10 $0 4 Chief Executive Officer, Director 06 Oct 2022, 18:11
/report/000120919122033779-gaspar-bobby-2022-06-01 Orchard Therapeutics plc 01 Jun 2022 2 $0 4 Chief Executive Officer, Director 03 Jun 2022, 08:00
/report/000120919122022988-gaspar-bobby-2022-04-01 Orchard Therapeutics plc 01 Apr 2022 1 +$11,085 4 Chief Executive Officer, Director 05 Apr 2022, 16:15